CompletedPHASE1, PHASE2NCT01490736

Phase 1/2 Sequentially Staged Safety Study in Healthy Subjects and Subjects With Mild Acne

Studying Anterior cutaneous nerve entrapment syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Dermira, Inc.
Principal Investigator
Robert Bissonnette, MD
Innovaderm Research Inc.
Intervention
Lemuteporfin(drug)
Enrollment
129 target
Eligibility
18 years · All sexes
Timeline
20112013

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01490736 on ClinicalTrials.gov

Other trials for Anterior cutaneous nerve entrapment syndrome

Additional recruiting or active studies for the same condition.

See all trials for Anterior cutaneous nerve entrapment syndrome

← Back to all trials